France’s Crossject Completes Europe’s First Biotech/MedTech IPO In 2014
This article was originally published in The Pink Sheet Daily
The French company’s gas-powered liquid-injection devices have similarities to the pyrotechnic powder technology used in seatbelt pretensioners in automobiles.
You may also be interested in...
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies.
The European Commission has extended the indications for Janssen’s Tremfya to include psoriatic arthritis, and those for BMS’s Opdivo to include gastroesophageal cancer.